Genetic Analysis AS - SER 2

XSAT:GEAN (Norway)   Unit (10 Ordinary shares,6 Wrts Ser 1 & 7 Wrts Ser 2)
kr 0.62 (+15.56%) Apr 22
At Loss
P/B:
0.74
Market Cap:
kr 26.31M ($ 2.40M)
Enterprise V:
kr 18.45M ($ 1.68M)
Volume:
215.45K
Avg Vol (2M):
148.71K
Also Trade In:
Volume:
215.45K
At Loss
Avg Vol (2M):
148.71K

Business Description

Genetic Analysis AS

ISIN : NO0010692130

Share Class Description:

XSAT:GEAN: Unit (10 Ordinary shares,6 Wrts Ser 1 & 7 Wrts Ser 2)
Description
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.
Name Current Vs Industry Vs History
Cash-To-Debt 2.06
Equity-to-Asset 0.6
Debt-to-Equity 0.23
Debt-to-EBITDA -0.41
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.26
Distress
Grey
Safe
Beneish M-Score -2.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 26.42
9-Day RSI 35.53
14-Day RSI 40.94
6-1 Month Momentum % -44.9
12-1 Month Momentum % -69.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.81
Quick Ratio 1.71
Cash Ratio 0.95
Days Inventory 141.62
Days Sales Outstanding 63.96
Days Payable 291.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15
Shareholder Yield % -15.28